Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease

Gerontology

Volumn 58, Issue 1, 2011, Pages 62-69

  Guan, Jing Zhi ^a   Guan, Wei Ping ^b   Maeda, Toyoki ^c   Makino, Naoki ^c  

^a 309TH HOSPITAL OF PLA   (China)

^b 301st Hospital of Chinese People's Liberation Army   (China)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; DNA methylation; Oxidative stress; Telomere; Vitamin E

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; BIOLOGICAL MARKER; DNA;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CELL DIVISION; CHROMOSOME; CONTROLLED STUDY; DNA METHYLATION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SOUTHERN BLOTTING; TELOMERE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DINOPROST; FEMALE; HUMANS; MALE; METHYLATION; OXIDATIVE STRESS; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TIME FACTORS; VITAMIN E;

EID: 84155167262     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000327821     Document Type: Article

References (56)

1. Fearnley JM, Lees AJ: Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
2. Roberts LJ II, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD: Formation of isoprostanelike compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 1998; 273: 13605-13612. (Pubitemid 28268404)
3. Pratico D, Lee VM-Y, Trojanowski JQ, Rokach J, Fitzgerald GA: Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo. FASEB 1998; 12: 1777-1783. (Pubitemid 28553673)
4. Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD: Increased CSF F2-isoprostane concentration in probable AD. Neurology 1999; 52: 562-565. (Pubitemid 29075604)
5. von Zglinicki T: Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344. (Pubitemid 34756516)
6. Pratico D: F(2)-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo. Atherosclerosis 1999; 147: 1-10. (Pubitemid 29486766)
7. Epel ES, Blackburn EH, Lin F, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM: Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312-17315. (Pubitemid 39627816)
8. Blackburn EH: Structure and function of telomeres. Nature 1991; 350: 569-573. (Pubitemid 21912269)
9. Zakian VA: Telomeres: Beginning to understand the end. Science 1995; 270: 1601-1607. (Pubitemid 26002435)
10. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458-460.
11. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 10114-10118.
12. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ: White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 842-846. (Pubitemid 36566175)
13. Ogami M, Ikura Y, Ohsawa M, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB: Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004; 24: 546-550. (Pubitemid 38326151)
14. Friedrich U, Gries E, Schwab M, Fritz P, Thon K, Klotz U: Telomere length in different tissues of elderly patients. Mech Ageing 2000; 119: 89-99.
15. Frenck RW Jr, Blackburn EH, Shannon KM: The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 1998; 95: 5607-5610. (Pubitemid 28224142)
16. McGeer EG, Yasojima K, Schwab C, McGeer PL: The pentraxins: Possible role in Alzheimer's disease and other innate inflammatory diseases. Neurobiol Aging 2001; 22: 843-848. (Pubitemid 34066551)
17. Querfurth HW, LaFerla FM: Alzheimer's disease. N Engl J Med 2010; 362: 329-344.
18. Benetti R, García-Cao M, Blasco MA: Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 2007; 39: 243-250. (Pubitemid 46184357)
19. Cross S, Lindsey J, Fantes J, McKay S, McGill N, Cooke H: The structure of a subterminal repeated sequence present on many human chromosomes. Nucleic Acids Res 1990; 18: 6649-6657.
20. Hansen RS, Wijmenga C, Luo P, et al: The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA 1999; 96: 14412-14417. (Pubitemid 30000664)
21. Yehezkel S, Segev Y, Viegas-Péquignot E, Skorecki K, Selig K: Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet 2008; 17: 2776-2789.
22. Maeda T, Guan JZ, Oyama J, Higuchi Y, Makino N: Aging-associated alteration of subtelomeric methylation in Parkinson's disease. J Gerontol A Biol Sci Med Sci 2009; 64: 949-955.
23. Maeda T, Guan JZ, Higuchi Y, Oyama J, Makino N: Aging-related alterations of subtelomeric methylation in sarcoidosis patients. J Gerontol A Biol Sci Med Sci 2009; 64: 752-760.
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, 1994, pp 104-152.
25. Ciabattoni G, Maclouf J, Catella F, FitzGerald GA, Patrono C: Radioimmunoassay of 11-dehydrothromboxane B 2 in human plasma and urine. Biochim Biophys Acta 1987; 918: 293-297. (Pubitemid 17065554)
26. Wang Z, Ciabattoni G, Créminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J: Immunological characterization of urinary 8-epi-prostaglandin F 2 alpha excretion in man. J Pharmacol Exp Ther 1995; 275: 94-100.
27. Gerss J, Köpcke W: The questionable association of vitamin E supplementation and mortality-inconsistent results of different meta-analytic approaches. Cell Mol Biol (Noisy-le-grand) 2009; 55(suppl):OL1111- OL1120.
28. Devaraj S, Tang R, Adams-Huet B, Harris A, Seenivasan T, de Lemos JA, Jialal I: Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007; 86: 1392-1398. (Pubitemid 350126243)
29. Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Suzuki T, Makino N: An analysis of telomere length in sarcoidosis. J Gerontol A Biol Sci Med Sci 2007; 62: 1199-1203. (Pubitemid 350287607)
30. Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Makino N: Change in the telomere length distribution with age in the Japanese population. Mol Cell Biochem 2007; 304: 353-360. (Pubitemid 47456884)
31. Guan JZ, Maeda T, Sugano M, Oyama J, Higuchi Y, Suzuki T, Makino N: A percentage analysis of the telomere length in Parkinson's disease patients. J Gerontol A Biol Sci Med Sci 2008; 63: 467-473.
32. Maeda T, Guan JZ, Oyama J, Higuchi Y, Makino N: Age-related changes in subtelomeric methylation in the normal Japanese population. J Gerontol A Biol Sci Med Sci 2009; 64: 426-434.
33. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM, Varmus HE: Structure and variability of human chromosome ends. Mol Cell Biol 1990; 10: 518-527.
34. Hemann MT, Strong MA, Hao LY, Greider CW: The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107: 67-77. (Pubitemid 32972038)
35. Cherif H, Tarry JL, Ozanne SE, Hales CN: Ageing and telomeres: A study into organand gender-specific telomere shortening. Nucl Acids Res 2003; 31: 1576-1583. (Pubitemid 36304920)
36. Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695. (Pubitemid 23350687)
37. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR: Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001; 103: 373-383. (Pubitemid 32201924)
38. Prasad KN, Cole WC, Hovland AR, Prasad KC, Nahreini P, Kumar B, Edwards-Prasad J, Andreatta CP: Multiple antioxidants in the prevention and treatment of neurodegenerative disease: Analysis of biologic rationale. Curr Opin Neurol 1999; 12: 761-770. (Pubitemid 30072360)
39. Rokach J, Khanapure SP, Hwang S-W, Adiyaman M, Lawson JA, FitzGerald GA: The isoprostanes: A perspective. Prostaglandins 1997; 54: 823-851. (Pubitemid 28124311)
40. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G: Widespread peroxynitrite- mediated damage in Alzheimer's disease. J Neurosci 1997; 17: 2653-2657. (Pubitemid 27154998)
41. Montine TJ, Markesbery WR, Morrow JD, Roberts LJ 2nd: Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Ann Neurol 1998; 44: 410-413. (Pubitemid 28421451)
42. Waddington E, Croft K, Clarnette R, Mori T, Martins R: Plasma F2-isoprostane levels are increased in Alzheimer's disease: Evidence of increased oxidative stress in vivo. Alzheimers' Rep 1999; 2: 277-282.
43. Pratico D, Clark CM, Lee VM, Trojanowski JQ, Rokach J, Fitzgerald GA: Increased 8,12-iso-iPF(2 alpha)-IV in Alzheimer's disease: Correlation of a specific noninvasive index of lipid peroxidation with disease severity. Ann Neurol 2000; 48: 809-812.
44. Tuppo EE, Forman LJ, Spur BW, Chan-Ting RE, Chopra A, Cavalieri TA: Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. Brain Res Bull 2001; 54: 565-568. (Pubitemid 32496555)
45. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI: Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 2008; 266: 6-11.
46. Wachsman JT: DNA methylation and the association between genetic and epigenetic changes: Relation to carcinogenesis. Mutat Res 1997; 375: 1-8. (Pubitemid 27152196)
47. Weitzman SA, Turk PW, Milkowski DH, Kozlowski K: Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci USA 1994; 91: 1261-1264. (Pubitemid 24058990)
48. Turk PW, Laayoun A, Smith SS, Weitzman SA: DNA adduct 8-hydroxyl-2α-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 1995; 16: 1253-1255.
49. Turk PW, Weitzman SA: Free radical DNA adduct 8-OH-deoxyguanosine affects activity of HPA II and MSP I restriction endonucleases. Free Radic Res 1995; 23: 255-258.
50. Kuchino Y, Mori F, Kasai H, et al: Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 1987; 327: 77-79. (Pubitemid 17063762)
51. Hepburn PA, Margison GP, Tisdale MJ: Enzymatic methylation of cytosine in DNA is prevented by adjacent O6-methylguanine residues. J Biol Chem 1991; 266: 7985-7987.
52. Tan N-W, Li BF: Interaction of oligonucleotides containing 6-O-methylguanine with human DNA (cytosine-5-)-methyltransferase. Biochemistry 1990; 29: 9234-9240. (Pubitemid 20320889)
53. Xiao W, Samson L: In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells. Proc Natl Acad Sci USA 1993; 90: 2117-2121. (Pubitemid 23078576)
54. Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, Rainfray M: Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001; 30: 235-241. (Pubitemid 32684904)
55. Kontush A, Mann U, Arlt S, Ujeyl A, Lührs C, Müller-Thomsen T, Beisiegel U: Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic Biol Med 2001; 31: 345-354. (Pubitemid 32675340)
56. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: The Alzheimer's Disease Cooperative Study. N Engl J Med 1997; 336: 1216-1222. (Pubitemid 27183651)